GlaxoSmithKline PLC (GSK.N)
20 Jan 2017
Thu, Jan 19 2017
* Miels was head of Astra's European business (Adds interview with GSK CEO in Davos, further details)
* Luke Miels appointed president, global pharmaceuticals, gsk
* Abbas hussain, president, global pharmaceuticals has decided to leave company. He has agreed with gsk that he will leave company later this year Source text for Eikon: Further company coverage: (Reporting By UK Bureau)
LONDON GlaxoSmithKline said on Tuesday its HIV unit ViiV Healthcare had started a large study to test an experimental long-acting injection for preventing the virus that causes AIDS.
LONDON GlaxoSmithKline's already fast-growing HIV drug business has received an important boost after two major clinical studies successfully tested a new two-drug treatment regimen to control the virus that causes AIDS.
LONDON Drugmaker GlaxoSmithKline is bolstering scientific expertise on its board by establishing a new science committee, charged with overseeing research, as a new chief executive prepares to take over.
LONDON GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah Waterhouse.
* GSK announces EU regulatory submission of candidate vaccine for prevention of shingles
LONDON GlaxoSmithKline has started pivotal trials of an experimental anemia drug, chasing AstraZeneca in the race to develop a medicine that mimics the body's response to high altitude.
LONDON, Nov 24 GlaxoSmithKline has started pivotal trials of an experimental anaemia drug, chasing AstraZeneca in the race to develop a medicine that mimics the body's response to high altitude.